R&D

Pipeline

Technology Target Product Indication Discovery Preclinical Clinical P1 Clinical P2
Antibody
(Tomaralimab)
TLR2 NM-101 PD arrow01      
NM-103 MSA arrow02      
BBB penetrating
Ab
BBB NM-301 PD, MSA arrow04   aptamer sciences  
Small molecule aSyn
aggregate
NM-401 PD arrow04   yungjin pharm  
NM-402 MSA arrow05   yungjin pharm  
Diagnostic aSyn
aggregate
NM-501 Diagnostics for
CNS disease
arrow06